Marine Gilabert

Institut Paoli-Calmettes ORCID: 0000-0003-1868-3260

1

h-index

1

Publications

211

Citations

Publications

1 shown

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès , Marine Gilabert , E. François +16 more

2012 Annals of Oncology 211 citations

Frequent Co-Authors

Anthony Gonçalvès

Institut Paoli-Calmettes

E. François

Centre Antoine Lacassagne

Laëtitia Dahan

Assistance Publique Hôpitaux de Marseille

Hervé Perrier

Hôpital Saint Joseph

R. Lamy

Centre Hospitalier de Bretagne Sud

Daniel Ré

Centre Hospitalier de Bigorre

Researcher Info

h-index: 1
Publications: 1
Citations: 211
Institution: Institut Paoli-Calmettes

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1868-3260

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.